Loading insider details...
Latest Form 4 (Sep 25, 2026): Sale of 104,320 MLYS shares, $3.01M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 104,320 | $3.01M |
| Feb 21, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 6,200 | n/a |
| Nov 21, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 1,000,000 | $43.35M |
| Apr 25, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Purchase | 259,259 | $3.50M |
| Feb 24, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 32,900 | n/a |
| Jan 7, 2025 | Mineralys Therapeutics, Inc. (MLYS) | Other (see footnotes) | 22,000 | n/a |
| Jul 27, 2024 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 550,000 | $7.18M |
| May 23, 2024 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 22,000 | n/a |
| Jul 14, 2023 | Mineralys Therapeutics, Inc. (MLYS) | Other (see footnotes) | 44,000 | n/a |
| Feb 16, 2023 | Mineralys Therapeutics, Inc. (MLYS) | Conversion | 4,314,093 | n/a |